MT
Mineralys Therapeutics, Inc. Common Stock
🇺🇸XNAS.MLYSUnited StatesHealthcare
$27.52USDdown -1.44 (-4.97%)After-hoursDelayed8:08 PM
Price$27.52-1.44 (-4.97%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US6031701013
- CUSIP
- 603170101
Company
- Employees
- 76
- Headquarters
- Radnor, United States
- Website
- https://mineralystx.com
- CEO
- Dr. Jon Congleton
Market
- Shares outstanding
- 88.4M
- Market cap
- $2.43B
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $2.53B
- EPS LTM
- -$3.95calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -6.96calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$349.58M-83.24%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$138.8M+27.98%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.